Skip to main content
WeightCited

Chromium Insulin Resistance

B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

Key Study Findings

Meta-Analysis
Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in …
Dose: Various vitamins and minerals vs: Placebo or standard care Outcome: Glycemic control and lipid metabolism 効果: None None

対象集団: T2DM patients in primary care (RCTs)

Review
Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS.
Dose: None vs: None Outcome: Menstrual cycle regulation 効果: None None

対象集団: Adolescents with PCOS

Controlled Clinical Trial n=77
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats …
Dose: leucine, zinc, and chromium alone/combined vs: vehicle-treated T2D rats Outcome: blood glucose and serum lipid profile 効果: None <0.05

対象集団: Male Wistar rats with type 2 diabetes

Key Statistics

25

研究数

2000

参加者数

Positive

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
25-35 mcg/day (AI)
weightmanagement:
200-1,000 mcg/day chromium picolinate
insulinsensitivity:
500-1,000 mcg/day

上限量: No established UL; long-term safety data at >1,000 mcg/day limited

研究で検討された用量

用量 期間 効果 N
Various vitamins and minerals -- Positive --
None -- Positive --
leucine, zinc, and chromium alone/combined -- Positive 77

推奨摂取タイミング: With meals

Safety & Side Effects

報告されている副作用

  • Headache
  • Insomnia
  • Mood changes
  • GI discomfort

既知の相互作用

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • Insulin
  • Sulfonylureas
  • Levothyroxine (reduced absorption)

耐容上限摂取量: No established UL; long-term safety data at >1,000 mcg/day limited

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Chromium help with Insulin Resistance?
Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
How much Chromium should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chromium?
Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chromium and Insulin Resistance?
We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

References

  1. [1] Jiayue Xia et al.. Pharmacol Res. 2023. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review … doi:10.1016/j.phrs.2023.106647 PubMed
  2. [2] Elisabeth Reiser et al.. J Clin Med. 2022. Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. doi:10.3390/jcm12010067 PubMed
  3. [3] Hassan Sadri et al.. Biol Trace Elem Res. 2017. Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes. doi:10.1007/s12011-017-1014-2 PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。